These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6653134)

  • 21. A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.
    Frick MH; Halttunen P; Himanen P; Huttunen M; Pörsti P; Pitkäjärvi T; Pöyhönen L; Pyykönen ML; Reinikainen P; Salmela P
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):55S-62S. PubMed ID: 2939868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of once-daily atenolol and metoprolol using office and ambulatory blood pressure monitoring.
    Rutan GH; Feig PU; May S; Kriegman AG; Brady EM
    J Clin Pharmacol; 1993 May; 33(5):418-26. PubMed ID: 8331198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of essential hypertension with beta-blocker plus diuretic: a study of 1402 patients treated by general practitioners with acebutolol 200 mg combined with hydrochlorothiazide 12.5 mg ('Secadrex') once daily for 3 months.
    McGowan GK; Baker PG
    J Int Med Res; 1984; 12(2):87-91. PubMed ID: 6373443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of atenolol and long-acting trimazosin in mild to moderate essential hypertension.
    Webb DJ; Hutcheson MJ; Robertson MP; Murray GD; Lorimer AR; Robertson JI
    Scott Med J; 1985 Apr; 30(2):106-10. PubMed ID: 3892676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly.
    Salvetti A; Lucchini M; Airoldi G; Cagianelli MA; Cinotti G; Cortese R; Diamanti G; Giuntoli F; Pedrinelli R; Pettinà G
    Eur J Clin Pharmacol; 1985; 29(3):275-9. PubMed ID: 3908126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
    Maclean D; Mitchell ET; Lewis R; Irvine N; McLay JS; McEwen J; Coulson RR; Slater ND; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Once-daily administration of acebutolol in treatment of hypertension.
    Weber MA; Drayer JI
    Am Heart J; 1985 May; 109(5 Pt 2):1175-8. PubMed ID: 2859782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open study of acebutolol, given as a single daily dose in the management of hypertension in the Chulalungkorn Hospital, Thailand.
    Ongcharit C; Goulton J; Baker PG
    J Int Med Res; 1980; 8(3):188-92. PubMed ID: 6993251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of acebutolol and propranolol in essential hypertension.
    Wahl J; Turlapaty P; Singh BN
    Am Heart J; 1985 Feb; 109(2):313-21. PubMed ID: 3880995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    J Hum Hypertens; 1987 Jun; 1(1):31-7. PubMed ID: 3334056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension.
    Dahlöf B; Keller SE; Makris L; Goldberg AI; Sweet CS; Lim NY
    Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of atenolol and oxprenolol in the treatment of arterial hypertension. A comparison.
    Turner AS; Watson OF; Brocklehurst JE
    Med J Aust; 1979 Jun; 1(13):625-6. PubMed ID: 386061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation.
    Wahl J; Singh BN; Thoden WR
    Am Heart J; 1986 Feb; 111(2):353-62. PubMed ID: 3511650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acebutolol (400 mg) given as a single daily dose to hypertensive patients previously stabilized on 400 mg acebutolol daily in divided doses: an open multicentre study.
    Ashton WL
    Curr Med Res Opin; 1977-1978; 5(4):347-53. PubMed ID: 630910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acebutolol in hypertension: relationships between drug concentration and effects.
    Martin MA; Phillips FC; Tucker GT; Smith AJ
    Eur J Clin Pharmacol; 1978 Dec; 14(6):383-90. PubMed ID: 367793
    [No Abstract]   [Full Text] [Related]  

  • 38. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of a new vasodilating beta-blocker, carvedilol, with atenolol in the treatment of mild to moderate essential hypertension.
    Ruilope LM
    Am J Hypertens; 1994 Feb; 7(2):129-36. PubMed ID: 7910028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxazosin in combination with atenolol in essential hypertension: a double-blind placebo-controlled multicentre trial.
    Searle M; Dathan R; Dean S; Christensen CC; Westheim A
    Eur J Clin Pharmacol; 1990; 39(3):299-300. PubMed ID: 2147909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.